SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001213900-24-013387
Filing Date
2024-02-13
Accepted
2024-02-13 17:00:07
Documents
1
Group Members
VIVO ASIA OPPORTUNITY FUND HOLDINGS, L.P.VIVO ASIA OPPORTUNITY, LLCVIVO OPPORTUNITY CO-INVEST, L.P.VIVO OPPORTUNITY, LLCVIVO PANDA FUND, L.P.VIVO PANDA, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G ea193538-13ga1vivo_gracell.htm SC 13G/A 172371
  Complete submission text file 0001213900-24-013387.txt   174227
Mailing Address BUILDING 3, 418 GUILIN ROAD XUHUI DISTRICT SHANGHAI F4 200030
Business Address BUILDING 3, 418 GUILIN ROAD XUHUI DISTRICT SHANGHAI F4 200030 00862164031522
Gracell Biotechnologies Inc. (Subject) CIK: 0001826492 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91967 | Film No.: 24627524
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 6506880818
Vivo Opportunity Fund Holdings, L.P. (Filed by) CIK: 0001930214 (see all company filings)

IRS No.: 873802421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A